Home
About
Why DFCR?
Strategic Vision
Platform of Regulations
Leadership
DFCR Experts
DFCR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Cannabis Curriculums
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Expert Testimony
Doctors for Cannabis Regulation
Expert Testimony
Expert Testimony
Opposing Maryland HB 23-1147: Cannabis-Induced Psychosis and THC Concentration Limit
Medical
3/1/23
DFCR Updates
DFCR Publishes White Paper on Legislating Cannabis Use in Healthcare Facilities
Medical
2/17/23
Expert Testimony
Expert Testimony Not Required for Colorado Senate Bill 081
Medical
2/17/23
Expert Testimony
Doctors for Cannabis Regulation Provides Testimony on Hawaii SB375
Adult Use
2/17/23
Expert Testimony
DFCR's Maryland Spokesperson Submits Written Testimony for General Assembly Committee In Support of HB556
Medical
2/16/23
Expert Testimony
Supporting Delaware HB 23-2-The Delaware Marijuana Control Act
Adult Use
1/24/23
Expert Testimony
Kansas Senate Bill SB 560
Medical
6/29/22
Expert Testimony
DFCR Calls for Delaware Veto Override of HB 371 - Cannabis Legalization
Adult Use
6/2/22
Expert Testimony
DFCR Letter to the House in Strong Support of the MORE Act
2/24/22
Expert Testimony
Delaware House Health and Human Development Committee HB 305
Adult Use
1/26/22
Expert Testimony
DFCR Letter to the House in Support of the MORE Act
10/1/21
Expert Testimony
New Jersey Cannabis Regulatory Commission: High potency THC, Edibles
Regulatory
6/2/21
Expert Testimony
Colorado House Public & Behavioral Health & Human Services HB21-1317
Regulatory
5/18/21
Expert Testimony
Alabama House SB46
Medical
4/26/21
Expert Testimony
Texas House Criminal Jurisprudence Committee HB3772
Penalty Reduction
Bryon Adinoff, MD
4/20/21
Expert Testimony
Delaware House Human Health Committee HB150
Adult Use
David L. Nathan, MD, DFAPA
3/24/21
Expert Testimony
Delaware House Human Health Committee HB150
Adult Use
Bryon Adinoff, MD
3/24/21
Expert Testimony
Connecticut General Assembly Judiciary SB888
Regulatory
Hugh Blumenfeld, MD, PhD
3/1/21
Expert Testimony
Connecticut General Assembly Judiciary SB888
Adult Use
Bryon Adinoff, MD
2/25/21
Expert Testimony
New York Legislature CRTA
Medical
Tanya Adams, DO
2/23/21
Expert Testimony
New Jersey Senate Judiciary AB1898
Adult Use
David L. Nathan, MD, DFAPA
2/22/21
Expert Testimony
Virginia Senate: Adult Use Cannabis
Adult Use
Bryon Adinoff, MD
1/31/21
Expert Testimony
Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)
Adult Use
1/1/21
Expert Testimony
US Senate Cannabis Administration and Opportunity Act
Regulatory
1/1/21
Expert Testimony
New Jersey Assembly Appropriations: Regulations
Regulatory
David L. Nathan, MD, DFAPA
11/20/20
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations
Adult Use
David L. Nathan, MD, DFAPA
11/10/20
Expert Testimony
Connecticut Senate Judiciary SB16
Adult Use
Bryon Adinoff, MD
3/3/20
Expert Testimony
Connecticut Senate Judiciary SB16
Adult Use
David L. Nathan, MD, DFAPA
3/3/20
Expert Testimony
US House Subcommittee Cannabis Policies for the New Decade
Adult Use
David L. Nathan, MD, DFAPA
1/18/20
Expert Testimony
Alabama House SB165
Medical
1/1/20
Expert Testimony
Alabama House SB165
Medical
1/1/20
Expert Testimony
Alabama House SB165
Medical
1/1/20
Expert Testimony
New Jersey General Assembly CR840
Monica Taing, PharmD
12/12/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical
Bryon Adinoff, MD
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical
Genester Wilson-King, MD, FACOG
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical
Donald O. Lyman, MD, DTPH
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical
Rachel Knox, MD
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical
Wendy Askew, MD
10/23/19
Expert Testimony
U.S. House: Congressional Committee Hearing on Cannabis Legalization
Adult Use
David L. Nathan, MD, DFAPA
7/10/19
Expert Testimony
Delaware House Revenue & Finance HB110
Adult Use
Bryon Adinoff, MD
6/5/19
Expert Testimony
Colorado Senate Medical Marijuana Code SB218
Medical
5/10/19
Expert Testimony
Vermont House Government Operations SB54
Regulatory
David L. Nathan, MD, DFAPA
4/30/19
Expert Testimony
South Carolina Medical Affairs S.366
Medical
Bryon Adinoff, MD
4/6/19
Expert Testimony
South Carolina Medical Affairs S.366
Medical
4/1/19
Expert Testimony
New Jersey Senate Judiciary SB2703
Adult Use
David L. Nathan, MD, DFAPA
3/19/19
Expert Testimony
Texas House Public Health HB1365
Medical
Bryon Adinoff, MD
3/16/19
Expert Testimony
Texas House Criminal Jurisprudence HB63
Penalty Reduction
Bryon Adinoff, MD
3/4/19
Expert Testimony
Vermont Senate Judiciary SB54
David L. Nathan, MD, DFAPA
2/1/19
Expert Testimony
New York General Assembly
Adult Use
12/1/18
Expert Testimony
New Jersey Senate Judiciary SB2703
Adult Use
11/1/18
Expert Testimony
New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse
Regulatory
David L. Nathan, MD, DFAPA
10/17/18
Expert Testimony
Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)
David L. Nathan, MD, DFAPA
4/30/18
Expert Testimony
New Jersey Division of Consumer Affairs Marijuana Reclassification
Regulatory
David L. Nathan, MD, DFAPA
4/25/18
Expert Testimony
U.S. FDA Cannabis Scheduling
Regulatory
David L. Nathan, MD, DFAPA
4/23/18
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization
David L. Nathan, MD, DFAPA
3/6/18
Expert Testimony
Illinois General Assembly SB316
Adult Use
David L. Nathan, MD, DFAPA
1/23/18
Expert Testimony
Testimony before the Illinois Senate on Marijuana Legalization
1/22/18
Expert Testimony
New Jersey Senate Judiciary Cannabis Adult Use
Adult Use
David L. Nathan, MD, DFAPA
6/19/17
Expert Testimony
Delaware House Revenue & Finance HB110
Adult Use
David L. Nathan, MD, DFAPA
5/11/17
Expert Testimony
Texas House Criminal Jurisprudence HB2107
Penalty Reduction
Bryon Adinoff, MD
5/3/17
Expert Testimony
California State Assembly AB1606
Regulatory
DFCR
4/14/17
Expert Testimony
Vermont House Human Services H.170
Adult Use
Bryon Adinoff, MD
4/12/17
Expert Testimony
Rhode Island House Judiciary HB5555
Adult Use
David L. Nathan, MD, DFAPA
4/12/17
Expert Testimony
Texas House Criminal Jurisprudence HB81
Penalty Reduction
Bryon Adinoff, MD
3/14/17
Expert Testimony
New Jersey Senate Judiciary
Adult Use
David L. Nathan, MD, DFAPA
11/17/15
DFCR Updates
Doctors for Cannabis Regulation (DFCR) Urges the United States Federal Government to Prioritize the Immediate Release of Brittney Griner from Detention in Russia
Penalty Reduction
Browse by Location
Alabama
California
Colorodo
Connecticut
Delaware
Federal
Hawaii
Illinois
International
Kansas
Maryland
Montana
New Jersey
New York
Pennsylvania
Rhode Island
South Carolina
Texas
Vermont
Virginia
Browse by Topic
Penalty Reduction
Regulatory
Medical
Adult Use
Support Our Mission
DONATE
JOIN